Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Explore why passive retirement investing tends to outperform active approaches over time, thanks to diversification, costs, and discipline.
21,397 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...
Agentic AI is shifting how machines act on goals, not just how they think. This piece explains why Jensen Huang’s vie...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
As volatility returns, smart investors ask which asset will shield wealth the best. This guide compares gold, silver,...
Rising medical costs are pushing families to cut meals and delay care, reshaping budgets and investment strategies am...
A hypothetical chair kevin warsh $6.7 balance sheet presents a tough puzzle for policy and markets. This article brea...
Silver prices climb in 2026, lifting pure-play silver miners trading below $30. Investors weigh the appeal of physica...
As AI floods daily choices, households face an accuracy of signals that can derail budgets. Edward Enninful’s human-c...
The SEC is signaling a shift in how ETFs operate, potentially opening doors for crypto investments. This guide explai...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...